Back to top

Image: Bigstock

Cerner and Hospital IQ Partner to Boost Clinical Awareness

Read MoreHide Full Article

Cerner Corporation recently collaborated with Hospital IQ, which is an intelligent automation company, to lend support to health systems with predictive analytics in order to boost clinical and operational awareness. With this partnership, Cerner is likely to bolster its already robust healthcare information technology (HCIT) footprint further.

Notably, Cerner is one of the largest pure-play HCIT companies and its wide presence, large reference-able client base and composite array of solutions make it an ideal candidate for investors seeking an exposure to the HCIT industry.

Significance of the Collaboration

The primary objective of this collaboration is to offer health systems with near real-time analytics and predictive capabilities to estimate and predict patient needs, thereby helping them in preparing better to coordinate resources across the hospital, emergency department and surgery rooms.

Health system operators, administrators and clinical leaders can improve foresight and knowledge of their operations for staff to take specific actions that can boost the delivery of care.



Interestingly, Cerner and Hospital IQ anticipate to work together to expand situational awareness throughout the health system. The combination of Hospital IQ’s Perioperative solution and Cerner’s data and analytics will enable health systems to effectively meet surgical demands and decide on resource allocation.

Another Collaboration

Cerner and Intermountain Healthcare, which is an integrated, not-for-profit health system, made an announcement of a multi-year expansion in February. The expansion reinforces both the organizations’ long-standing commitment toward improvement of the safety, quality and experience of health care for patients and caregivers.

Market Prospects

Per a report by Allied Market Research, global healthcare IT market (HCIT) is expected to reach $297 billion by 2022 at a CAGR of 13.2% during the forecast period of 2016-2022. Rise in demand for quality healthcare services and solutions along with patient safety and care, proactive supportive government initiatives and increase in acceptance of mHealth and telehealth practices are factors driving the market. Further, growing adoption of smartphones and patient-doctor convenience are also contributing to the market’s growth.

Price Performance

Shares of this Zacks Rank #4 (Sell) stock lost 4.7% in a year’s time, against the industry’s growth of 5.7%.

Key Picks

Some better-ranked stocks from the broader medical space include Aphria Inc. , HMS Holdings Corp. and West Pharmaceutical Services, Inc. (WST - Free Report) , each currently carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Aphria has an estimated long-term earnings growth rate of 24.6%.

HMS Holdings has an estimated long-term earnings growth rate of 11%.

West Pharmaceutical has a projected long-term earnings growth rate of 9.2%.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>


Unique Zacks Analysis of Your Chosen Ticker


Pick one free report - opportunity may be withdrawn at any time


West Pharmaceutical Services, Inc. (WST) - $25 value - yours FREE >>

Published in